483 Pharmaron May 2019

483 Pharmaron May 2019

Debra Boyd Seale FDA, Zhou Chen FDA, Marijo Kambere FDA, Mark Seaton FDA$119.00 - Available Now

FDA investigators audited the Pharmaron - Beijing, China facility and issued inspectional observations (via FDA 483) on 24 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2019
  • Location: Beijing, China
  • FEI: 3009887161
Add To Cart